Literature DB >> 18931646

Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.

John M Lasak1, Darren Klish, Thomas C Kryzer, Chris Hearn, John P Gorecki, Grant P Rine.   

Abstract

OBJECTIVE: To evaluate the hearing outcomes for a group of unilateral vestibular schwannoma patients treated with gamma knife radiosurgery and to determine if the cochlear radiation dose affects hearing outcome measures. STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary referral center. PATIENTS: Vestibular schwannoma patients (n = 33) treated with gamma knife with complete audiometric follow-up. INTERVENTION: Gamma knife radiosurgery and audiometry. MAIN OUTCOME MEASURES: Pure-tone average (PTA), speech discrimination score (SDS), and cochlear radiation dose.
RESULTS: The median audiometric follow-up was 24 months, with a range of 6 to 51 months (mean, 24.6 mo; standard deviation [SD], 13.9). Thirty-one patients received a maximum radiation dose of 26 Gy, and 2 received 24 Gy (mean, 25.9 Gy; SD, 0.48). All patients were treated to the 50% isodose line, and the prescription isodose was 13 Gy in 31 patients and 12 Gy in 2 patients (mean, 12.9 Gy; SD, 0.24). Mean pretreatment PTA and SDS were 55.86 dB and 45.70%, respectively. Mean PTA and SDS at last follow-up were 66.55 dB and 39.15%, respectively. The PTA at 6 months (p = 0.003), 12 months (p = 0.004), and last follow-up (p = 0.001) was significantly poorer than the pretreatment PTA. There was no significant difference between pretreatment and follow-up SDS at any time interval. The mean cochlear radiation dose was 5.2 Gy (range, 2.6-8.5 Gy). The median cochlear dose was 4.75 Gy. Fifteen patients received less than the median cochlear dose, and 18 received greater than or equal to the median cochlear dose. The change in PTA from baseline was significantly poorer at 12 months for those patients whose cochlea received 4.75 Gy (p = 0.02) or greater. Stepwise linear regression analysis using the variables of minimum SDS subsequent to baseline SDS versus total cochlear dose revealed a negative correlation (p = 0.012)-as total cochlear dose increased, SDS decreased.
CONCLUSION: The PTA was significantly worse after gamma knife radiosurgery, with a mean follow-up of 24.6 months. Higher radiation doses to the cochlear volume negatively impacted hearing outcomes after radiosurgery for this group of vestibular schwannoma patients.

Entities:  

Mesh:

Year:  2008        PMID: 18931646     DOI: 10.1097/MAO.0b013e31818b6639

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  12 in total

Review 1.  The biology of radiosurgery and its clinical applications for brain tumors.

Authors:  Douglas Kondziolka; Samuel M Shin; Andrew Brunswick; Irene Kim; Joshua S Silverman
Journal:  Neuro Oncol       Date:  2014-09-28       Impact factor: 12.300

2.  Long-term hearing preservation after microsurgical excision of vestibular schwannoma.

Authors:  Erika Ann Woodson; Ryan Douglas Dempewolf; Samuel Paul Gubbels; Aaron Thomas Porter; Jacob Jay Oleson; Marlan Rex Hansen; Bruce Jay Gantz
Journal:  Otol Neurotol       Date:  2010-09       Impact factor: 2.311

3.  Stereotactic radiotherapy of vestibular schwannoma : Hearing preservation, vestibular function, and local control following primary and salvage radiotherapy.

Authors:  Florian Putz; Jan Müller; Caterina Wimmer; Nicole Goerig; Stefan Knippen; Heinrich Iro; Philipp Grundtner; Ilker Eyüpoglu; Karl Rössler; Sabine Semrau; Rainer Fietkau; Sebastian Lettmaier
Journal:  Strahlenther Onkol       Date:  2016-12-07       Impact factor: 3.621

Review 4.  A review of treatment modalities for vestibular schwannoma.

Authors:  Benjamin J Arthurs; Robert K Fairbanks; John J Demakas; Wayne T Lamoreaux; Neil A Giddings; Alexander R Mackay; Barton S Cooke; Ameer L Elaimy; Christopher M Lee
Journal:  Neurosurg Rev       Date:  2011-02-09       Impact factor: 3.042

5.  Impact of Cochlear Dose on Hearing Preservation following Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma.

Authors:  Lawrance K Chung; Nolan Ung; John P Sheppard; Thien Nguyen; Carlito Lagman; Winward Choy; Stephen Tenn; Nader Pouratian; Percy Lee; Tania Kaprealian; Michael Selch; Antonio De Salles; Quinton Gopen; Isaac Yang
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-10

6.  Systematic Review of Hearing Preservation After Radiotherapy for Vestibular Schwannoma.

Authors:  Adam R Coughlin; Tyler J Willman; Samuel P Gubbels
Journal:  Otol Neurotol       Date:  2018-03       Impact factor: 2.311

7.  Stereotactic radiosurgery does not appear to impact cochlear implant performance in patients with neurofibromatosis type II.

Authors:  Justyn Pisa; Jacob Sulkers; James B Butler; Michael West; Jordan B Hochman
Journal:  J Radiosurg SBRT       Date:  2017

8.  Cochlear implantation in patients with neurofibromatosis type 2 and patients with vestibular schwannoma in the only hearing ear.

Authors:  Erika Celis-Aguilar; Luis Lassaletta; Javier Gavilán
Journal:  Int J Otolaryngol       Date:  2012-02-28

9.  Surgical approaches to tinnitus treatment: A review and novel approaches.

Authors:  Teo Soleymani; David Pieton; Patrick Pezeshkian; Patrick Miller; Alessandra A Gorgulho; Nader Pouratian; Antonio A F De Salles
Journal:  Surg Neurol Int       Date:  2011-10-29

10.  Hearing preservation surgery in acoustic neuroma. Slow progress and new strategies.

Authors:  A Mazzoni; F Biroli; C Foresti; A Signorelli; C Sortino; E Zanoletti
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-04       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.